Your browser doesn't support javascript.
loading
Bipolar I and bipolar II subtypes in older age: Results from the Global Aging and Geriatric Experiments in Bipolar Disorder (GAGE-BD) project.
Beunders, Alexandra J M; Klaus, Federica; Kok, Almar A L; Schouws, Sigfried N T M; Kupka, Ralph W; Blumberg, Hilary P; Briggs, Farren; Eyler, Lisa T; Forester, Brent P; Forlenza, Orestes V; Gildengers, Ariel; Jimenez, Esther; Mulsant, Benoit H; Patrick, Regan E; Rej, Soham; Sajatovic, Martha; Sarna, Kaylee; Sutherland, Ashley; Yala, Joy; Vieta, Eduard; Villa, Luca M; Korten, Nicole C M; Dols, Annemieke.
Afiliação
  • Beunders AJM; GGZ inGeest Specialized Mental Health Care, Old Age Psychiatry, Amsterdam, The Netherlands.
  • Klaus F; Amsterdam UMC location Vrije Universiteit Amsterdam, Psychiatry, Amsterdam, The Netherlands.
  • Kok AAL; Amsterdam Public Health research institute, Mental Health, Amsterdam, The Netherlands.
  • Schouws SNTM; Department of Psychiatry, University of California San Diego, San Diego, California, USA.
  • Kupka RW; Desert-Pacific Mental Illness Research Education and Clinical Center, VA San Diego Healthcare System, San Diego, USA.
  • Blumberg HP; GGZ inGeest Specialized Mental Health Care, Old Age Psychiatry, Amsterdam, The Netherlands.
  • Briggs F; Amsterdam UMC location Vrije Universiteit Amsterdam, Psychiatry, Amsterdam, The Netherlands.
  • Eyler LT; Amsterdam Public Health research institute, Mental Health, Amsterdam, The Netherlands.
  • Forester BP; GGZ inGeest Specialized Mental Health Care, Old Age Psychiatry, Amsterdam, The Netherlands.
  • Forlenza OV; Amsterdam UMC location Vrije Universiteit Amsterdam, Psychiatry, Amsterdam, The Netherlands.
  • Gildengers A; Amsterdam Public Health research institute, Mental Health, Amsterdam, The Netherlands.
  • Jimenez E; GGZ inGeest Specialized Mental Health Care, Old Age Psychiatry, Amsterdam, The Netherlands.
  • Mulsant BH; Amsterdam UMC location Vrije Universiteit Amsterdam, Psychiatry, Amsterdam, The Netherlands.
  • Patrick RE; Amsterdam Public Health research institute, Mental Health, Amsterdam, The Netherlands.
  • Rej S; Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA.
  • Sajatovic M; Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
  • Sarna K; Department of Psychiatry, University of California San Diego, San Diego, California, USA.
  • Sutherland A; Desert-Pacific Mental Illness Research Education and Clinical Center, VA San Diego Healthcare System, San Diego, USA.
  • Yala J; Division of Geriatric Psychiatry, McLean Hospital, Belmont, Massachusetts, USA.
  • Vieta E; Harvard Medical School, Boston, Massachusetts, USA.
  • Villa LM; Laboratory of Neuroscience (LIM27), Department and Institute of Psychiatry, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo HCFMUSP, São Paulo, Brazil.
  • Korten NCM; Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Dols A; Bipolar and Depressive Disorders Unit, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain.
Bipolar Disord ; 25(1): 43-55, 2023 02.
Article em En | MEDLINE | ID: mdl-36377516
ABSTRACT

OBJECTIVES:

The distinction between bipolar I disorder (BD-I) and bipolar II disorder (BD-II) has been a topic of long-lasting debate. This study examined differences between BD-I and BD-II in a large, global sample of OABD, focusing on general functioning, cognition and somatic burden as these domains are often affected in OABD.

METHODS:

Cross-sectional analyses were conducted with data from the Global Aging and Geriatric Experiments in Bipolar Disorder (GAGE-BD) database. The sample included 963 participants aged ≥50 years (714 BD-I, 249 BD-II). Sociodemographic and clinical factors were compared between BD subtypes including adjustment for study cohort. Multivariable analyses were conducted with generalized linear mixed models (GLMMs) and estimated associations between BD subtype and (1) general functioning (GAF), (2) cognitive performance (g-score) and (3) somatic burden, with study cohort as random intercept.

RESULTS:

After adjustment for study cohort, BD-II patients more often had a late onset ≥50 years (p = 0.008) and more current severe depression (p = 0.041). BD-I patients were more likely to have a history of psychiatric hospitalization (p < 0.001) and current use of anti-psychotics (p = 0.003). Multivariable analyses showed that BD subtype was not related to GAF, cognitive g-score or somatic burden.

CONCLUSION:

BD-I and BD-II patients did not differ in terms of general functioning, cognitive impairment or somatic burden. Some clinical differences were observed between the groups, which could be the consequence of diagnostic definitions. The distinction between BD-I and BD-II is not the best way to subtype OABD patients. Future research should investigate other disease specifiers in this population.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Bipolar / Disfunção Cognitiva Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: Bipolar Disord Assunto da revista: PSIQUIATRIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Bipolar / Disfunção Cognitiva Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: Bipolar Disord Assunto da revista: PSIQUIATRIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda